Effects of Continuous Administration of Clopidogrel Before Off-Pump Coronary Artery Bypass Grafting in Patients With Acute Coronary Syndrome A Propensity Score Analysis
Open Access
- 1 January 2007
- journal article
- Published by Japanese Circulation Society in Circulation Journal
- Vol. 72 (4) , 626-632
Abstract
Background Clopidogrel has become standard treatment after urgent percutaneous coronary revascularization. Due to its enhanced and irreversible platelet inhibition, patients undergoing urgent surgical revascularization have a higher risk of bleeding complications and transfusions. Therefore, the effect of preoperative continuous administration of clopidogrel on the incidence of hemorrhagic complications in patients undergoing off-pump coronary artery bypass surgery with acute coronary syndrome was evaluated. Methods and Results From March 2004 to September 2006, 172 patients with acute coronary syndrome underwent isolated off-pump coronary artery bypass surgery; 70 (40.7%) and 102 (59.3%) of these patients did or did not take clopidogrel before surgery respectively. Seventy patients in each group were matched using propensity scores and associations between preoperative continuous administration of clopidogrel and postoperative bleeding, hemostatic reoperation, blood products received, the need for multiple transfusions and early graft patency by coronary computed tomography were assessed. Univariate analysis showed the continuous clopidogrel group had similar levels of postoperative bleeding for 24 h (601.4±312.6 ml vs 637.2±452.4 ml, p=0.616) and rates of reexploration (1.4% vs 1.4%), perioperative blood transfusion (33.3% vs 34.3%, p>0.05) and platelet transfusion (2.9% vs 7.1%, p=0.44) compared with the non-continuous group. Conclusions Preoperative continuous administration of clopidogrel did not increase the risk of hemorrhagic complications in patients with acute coronary syndrome undergoing isolated off-pump coronary artery bypass surgery. These findings indicate that surgery after clopidogrel treatment in patients with acute coronary syndrome should not be delayed until platelet function returns to normal because they may have a higher risk of recurrent myocardial ischemic events. (Circ J 2008; 72: 626 - 632)Keywords
This publication has 23 references indexed in Scilit:
- Effects of preoperative aspirin and clopidogrel therapy on perioperative blood loss and blood transfusion requirements in patients undergoing off-pump coronary artery bypass graft surgeryThe Journal of Thoracic and Cardiovascular Surgery, 2007
- Urgent or Emergent Coronary Revascularization Using Bilateral Internal Thoracic Artery after Previous Clopidogrel Antiplatelet TherapyThe Thoracic and Cardiovascular Surgeon, 2003
- The effect of clopidogrel incombination with aspirin whengiven before coronary artery bypass graftingJACC, 2002
- The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme. Rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular diseaseEuropean Heart Journal, 2000
- Comparative Safety and Tolerability of Clopidogrel and AspirinDrug Safety, 1999
- Minimally invasive coronary artery bypass graftingThe Annals of Thoracic Surgery, 1996
- The contribution of fibrinolysis to postbypass bleedingJournal of Cardiothoracic and Vascular Anesthesia, 1991
- TRANSESOPHAGEAL ECHOCARDIOGRAPHY DURING ORTHOTOPIC LIVER TRANSPLANTATIONAnesthesiology, 1991
- Bleeding after Cardiopulmonary BypassNew England Journal of Medicine, 1986
- Hemostasis Changes During Cardiopulmonary Bypass SurgerySeminars in Thrombosis and Hemostasis, 1985